NCT02049255View on ClinicalTrials.gov

Comparision of the Use in Marcaine and Chloroprocaine in Rachianesthesia for the Surgical Correction of Inguinal Hernia.

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Pain
Interventions
DRUG

Chloroprocaine

"The Group Chloroprocaine will receive: Chloroprocaine: 50 mg in rachianesthesia"

DRUG

Marcaine

"The Group Marcaine will receive: Marcaine: 12,5 mg in rachianesthesia"

Trial Locations (1)

5004

Clinique Saint-Luc Bouge, Bouge

Sponsors

Lead Sponsor

Astes
All Listed Sponsors
lead

Astes

OTHER

NCT02049255 - Comparision of the Use in Marcaine and Chloroprocaine in Rachianesthesia for the Surgical Correction of Inguinal Hernia. | Biotech Hunter | Biotech Hunter